How M.D. was paid
$7.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Alise Reicin, M.D.President, CEO and Director | $640,833 | $1,946,853 | $4,373,617 | $372,500 | $17,775 | $7,351,578 |
| Daniel Lochner, M.B.A.Chief Financial Officer | $488,854 | $947,608 | $1,424,794 | $206,500 | $33,358 | $3,101,114 |
| Marcella K. Ruddy, M.D.Chief Medical Officer | $501,050 | $937,219 | $1,409,161 | $211,700 | $10,500 | $3,069,630 |
What changed and why
- $7.4MCEO total compensation increased to $7,351,578 in fiscal 2025 from $5,900,217 in fiscal 2024.
- 105%Named executive officers were eligible to receive 105% of their target annual bonus for fiscal 2025.
- Dr. Reicin received option and restricted stock unit grants in February and September 2025.
- Annual base salaries for executive officers were adjusted effective March 1, 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.